ClinicalTrials.Veeva

Menu

Study to Determine Racial and Gender Differences in Platelet Aggregation

T

Texas Tech University Health Sciences Center

Status

Completed

Conditions

Platelet Aggregation

Treatments

Procedure: Blood Draw

Study type

Observational

Funder types

Other

Identifiers

NCT00233428
L05-108

Details and patient eligibility

About

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Full description

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Race of Caucasian, African American, or Hispanic

Exclusion criteria

  • Chronic medical conditions
  • Tobacco use
  • Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems